PUBLISHER: Inkwood Research | PRODUCT CODE: 1077340
PUBLISHER: Inkwood Research | PRODUCT CODE: 1077340
The North America medical thawing system market growth is set to record a CAGR of 7.37% during the forecast period, 2022-2030. The region is considered the center of blood plasma therapy R&D, incorporated into various treatment methods. Also, cold storage vaccines are administered widely in North America. Vaccines, stored at an extremely lower temperature in liquid nitrogen, must be warmed before vast usage.
The North America medical thawing system market growth evaluation includes the analysis of the United States and Canada. Canada has a well-developed healthcare infrastructure. As of 2019, the country has 1200 hospitals. Also, it has a conducive trade relationship with the United States. Since the US is home to several key medical thawing companies, it helps Canada to import thawing devices with minimal tariffs under the North American Free Trade Agreement (NAFTA). Additionally, the number of motor vehicle fatalities was 1745 in 2020. Vehicular accidents raise the need for blood transfusion, thereby enabling growth opportunities.
Furthermore, the research organizations in the country explore the potential benefits of blood plasma. Besides, the presence of molecular R&D laboratories facilitates 3D cell culture market growth, further enabling growth opportunities for the market analyzed.
Some of the leading firms in the market include: Cardinal Health, Boekel Scientific, Caron Products & Services Inc, BioLife Solutions Inc, etc.